Clinical Trials Sponsored by Glenn Foundation for Medical Research

Total 3778 results

Montefiore Medical Center
Glenn Foundation for Medical Research

Withdrawn

Time Course for Fasting-induced Autophagy in Humans

Fasting | Aging Well | Autophagy | Ketosis, Metabolic

United States
Glenn Bauman
London Health Sciences Foundation

Active, not recruiting

Radioligand fOr locAl raDiorecurrent proStaTe cancER (ROADSTER)

Prostate Cancer

Canada
Foundation for Liver Research
Erasmus Medical Center

Completed

Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer. (LAPC-1)

Pancreatic Neoplasms

Netherlands
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Disease

United States
Foundation for Liver Research
Erasmus Medical Center

Completed

Influence of Ribavirin and Interferon on Semen Quality, IRIS Study (IRIS)

Sperm Motility (Focus of Study)

Netherlands
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Parkinson Disease

United States
Foundation for Liver Research

Completed

Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

Liver Disease

Netherlands
Foundation for Liver Research

Completed

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B (ARES)

Chronic Hepatitis B

Netherlands, China, Romania, Turkey, Poland
Foundation for Liver Research

Completed

Colesevelam Versus Placebo in Cholestatic Pruritus (COPE)

Chronic Liver Disease

Netherlands
Foundation for Liver Research

Completed

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's (Adafi)

Crohn's Disease With Perianal Fistulas

Netherlands
Foundation for Liver Research

Completed

Entecavir for Chronic Hepatitis B

Entecavir for Chronic Hepatitis B Patients

Netherlands
Foundation for Liver Research

Completed

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B

Netherlands
Foundation for Liver Research

Completed

KRN7000 in Chronic Hepatitis B

Hepatitis B, Chronic

Netherlands
Foundation for Sarcoidosis Research

Recruiting

Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

Sarcoidosis

United States
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Foundation for Liver Research

Completed

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients (ImmunoDual)

Chronic Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study (GIANT-B)

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Withdrawn

Pancreatic Enzyme Suppletion in Pancreatic Cancer (EPC)

Adenocarcinoma of the Pancreas | Normal Pancreatic Exocrine Function

Netherlands
Foundation for Liver Research

Completed

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders (SCIN-C)

Chronic Hepatitis C

Netherlands
Foundation for Sarcoidosis Research

Recruiting

Routine Cardiac Screening in Sarcoidosis Patients (PAPLAND)

Sarcoidosis | Cardiac Sarcoidosis | Boeck's Disease | Besnier-Boeck Disease

United States, United Kingdom, Netherlands
Foundation for Liver Research

Completed

Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures (COPAC)

Esophageal Cancer | Esophageal Stenosis

Netherlands
Foundation for Liver Research

Completed

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. (CIRES)

Hepatitis C | Immunology | Liver | Regulation

Netherlands
Foundation for Liver Research

Completed

PEG-IFN in HBV Patients With Incomplete Response to NA (PADD)

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Completed

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

Hepatitis C

Netherlands
Foundation for Liver Research

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Chronic Hepatitis B

Netherlands
Foundation for Liver Research

Completed

Pegintron Induction Therapy in HCV Non-Responders

Hepatitis C

Netherlands
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Validation of Dyskinesia Rating Scales

Parkinson's Disease

United States, Austria, Canada, France
Maastricht University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Cognitive Behavioural Therapy for Anxiety Disorders in PD

Parkinson's Disease | Generalized Anxiety Disorder | Social Phobia

France, Netherlands
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Improve Speech Using an In-the-ear Device in Parkinson's Disease (MJFFSpeech)

Parkinson's Disease | Dysarthria

United States
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease (TALISMAN)

Parkinson Disease | Effect of Drug

Netherlands
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

PERsonalized SPEeCh Therapy for actIVE Conversation (PERSPECTIVE)

Parkinson Disease

Netherlands
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Terminated

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease (TOP-DYSK)

Idiopathic Parkinson's Disease | Drug Induced Dyskinesia

United States
Dartmouth-Hitchcock Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Prism Adaptation Treatment of Parkinson's Disease

Parkinson

United States
Samsung Medical Center
Korean Foundation for Cancer Research

Unknown

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Lung Adenocarcinoma

Korea, Republic of
Maimonides Medical Center
Foundation for Prader-Willi Research

Recruiting

Impact of Bright Light Therapy on Prader-Willi Syndrome (PWS-LT)

Body Weight | Hyperphagia | Prader-Willi Syndrome | Mood | Behavior | Excessive Daytime Sleepiness

United States
Centre Hospitalier Intercommunal Creteil
Foundation for Medical Research

Not yet recruiting

Impact of Chronic Rhinosinusitis on the Index of Ciliary Beat Efficiency Using Fluorescent Nanosticks: (R-IMPAC) (R-IMPAC)

Chronic Rhinosinusitis (Diagnosis)

France
Montefiore Medical Center
Foundation for Prader-Willi Research

Completed

Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome (OXT-PWS)

Hyperphagia | Prader-Willi Syndrome

United States
Foundation for Cardiovascular Research, Zurich
Abbott Medical Devices

Unknown

PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

Heart Septal Defects, Atrial | Embolism, Paradoxical

Australia, Austria, Belgium, Switzerland
Takeda
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study of TAK-071 in People With Parkinson Disease

Parkinson Disease | Healthy Participants

United States
Michael J. Fox Foundation for Parkinson's Research
Sanofi

Terminated

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

Parkinson's Disease

United States
CHDI Foundation, Inc.
Dr. Glenn T. Stebbins (Rush University Medical Center ); Dr. Nancy LaPelle

Completed

FuRST 2.0 Cognitive Pre-testing - Round 2

Huntington Disease

United States, Canada
Glenn J. Hanna
Adenoid Cystic Carcinoma Research Foundation; Cellestia Biotech AG

Recruiting

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Adenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic Carcinoma

United States
Egyptian Foundation For Cancer Research

Completed

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma (MERITS)

Metastatic Renal Cell Carcinoma

Egypt
Foundation for Cardiovascular Research, Zurich

Unknown

Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison

Coronary Artery Disease
Medical University of South Carolina
Michael J. Fox Foundation for Parkinson's Research

Completed

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) (ATM-Cog)

Parkinson's Disease | Cognitive Impairment

United States
Beth Israel Deaconess Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment (SING-PD)

Voice Quality and Voice Loudness Associated With Parkinson's Disease

United States
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort (PPMI)

Parkinson Disease

United States, Canada, Spain, Israel, Austria, Germany, Greece, Italy, Netherlands, Nigeria, United Kingdom, Luxembourg
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders

Completed

PPMI Tau PET Imaging

Parkinson Disease

United States
National Foundation for Fertility Research

Completed

An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro

Infertility | Reproductive Techniques, Assisted

United States

Clinical Trials Sponsored by Glenn Foundation for Medical Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations